NEW YORK, May 1, 2023 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IVERIC bio, Inc. (“IVERIC” or the “Company”) (NASDAQ: ISEE), in connection with its proposed acquisition by Astellas Pharma Inc….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.